Do cereal mixed-linked β-glucans possess immune-modulating activities?

Molecular Nutrition and Food Research

Volumn 56, Issue 4, 2012, Pages 536-547

  Rieder, Anne ^a   Samuelsen, Anne Berit ^b  

^a NOFIMA   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

Anti cancer activity; Cereal glucan; Immune modulation; Structure functional relationship; Uptake

Indexed keywords

ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT; BETA GLUCAN; IMMUNOLOGIC FACTOR;

ANIMAL; BACTERIAL INFECTION; CEREAL; CHEMISTRY; HUMAN; INTESTINE; INTESTINE INFECTION; PARASITOLOGY; REVIEW;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTINEOPLASTIC AGENTS; BACTERIAL INFECTIONS; BETA-GLUCANS; CEREALS; HUMANS; IMMUNOLOGIC FACTORS; INTESTINAL DISEASES, PARASITIC; INTESTINES;

ANIMALIA; BACTERIA (MICROORGANISMS);

EID: 84859776970     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201100723     Document Type: Review

References (92)

1. Mizuno, M., Minato, K., Ito, H., Kawade, M. et al., Anti-tumor polysaccharide from the mycelium of liquid-cultured Agaricus blazei mill. Biochem. Mol. Biol. Int. 1999, 47, 707-714.
2. Thompson, I. J., Oyston, P. C. F., Williamson, D. E., Potential of the beta-glucans to enhance innate resistance to biological agents. Expert Rev. Anti-Infect. Ther. 2010, 8, 339-352.
3. Lehne, G., Haneberg, B., Gaustad, P., Johansen, P. W. et al., Oral administration of a new soluble branched beta-1, 3-D-glucan is well tolerated and can lead to increased salivary concentrations of immunoglobulin A in healthy volunteers. Clin. Exp. Immunol. 2006, 143, 65-69.
4. Ramberg, J. E., Nelson, E. D., Sinnott, R. A., Immunomodulatory dietary polysaccharides: a systematic review of the literature. Nutr. J. 2010, 9, 54.
5. Jonker, D., Hasselwander, O., Tervila-Wilo, A., Tenning, P. P., 28-Day oral toxicity study in rats with high purity barley beta-glucan (Glucagel (TM)). Food Chem. Toxicol. 2010, 48, 422-428.
6. Volman, J. J., Ramakers, J. D., Plat, J., Dietary modulation of immune function by beta-glucans. Physiol. Behav. 2008, 94, 276-284.
7. Soltanian, S., Stuyven, E., Cox, E., Sorgeloos, P. et al., Beta-glucans as immunostimulant in vertebrates and invertebrates. Crit. Rev. Microbiol. 2009, 35, 109-138.
8. EFSA, Panel on Dietetic Products, Nutrition and Allergies (NDA); Scientific Opinion on the substantiation of a health claim related to oat beta-glucan and lowering blood cholesterol and reduced risk of (coronary) heart disease pursuant to Article 14 of Regulation (EC) No 1924/2006. EFSA J. 2010, 8(12):1885. DOI:10.2903/j.efsa.2010.1885.
9. Lazaridou, A., Biliaderis, C. G., Izydorczyk, M. S., in: Biliaderis, C. G., Izydorczyk, M. S. (Eds.), Functional Food Carbohydrates, CRC Press, Boca Raton 2007, pp. 1-72.
10. Wood, P. J., Weisz, J., Blackwell, B. A., Structural studies of (1-]3), (1-]4)-beta-D-glucans by C (13)-nuclear magnetic-resonance spectroscopy and by rapid analysis of cellulose-like regions using high-performance anion-exchange chromatorgraphy of oligosaccharides release by lichenase. Cereal Chem. 1994, 71, 301-307.
11. Lazaridou, A., Biliaderis, C. G., Molecular aspects of cereal beta-glucan functionality: physical properties, technological applications and physiological effects. J. Cereal Sci. 2007, 46, 101-118.
12. Knutsen, S. H., Holtekjolen, A. K., Preparation and analysis of dietary fibre constituents in whole grain from hulled and hull-less barley. Food Chem. 2007, 102, 707-715.
13. Bohn, J. A., BeMiller, J. N., (1->3)-beta-D-glucans as biological response modifiers: a review of structure-functional activity relationships. Carbohydr. Polym. 1995, 28, 3-14.
14. Beer, M. U., Wood, P. J., Weisz, J., Molecular weight distribution and (1->3)(1->4)-beta-D-glucan content of consecutive extracts of various oat and barley cultivars. Cereal Chem. 1997, 74, 476-480.
15. Wood, P. J., Relationships between solution properties of cereal beta-glucans and physiological effects-a review. Trends Food Sci. Technol. 2004, 15, 313-320.
16. Li, W., Cui, S. W., Wang, Q., Yada, R. Y., Studies of aggregation behaviours of cereal beta-glucans in dilute aqueous solutions by light scattering: part I. Structure effects. Food Hydrocolloids 2011, 25, 189-195.
17. Morgan, K. R., Roberts, C. J., Tendler, S. J. B., Davies, M. C. et al., A C-13 CP MAS NMR spectroscopy and AFM study of the structure of Glucagel (TM), a gelling beta-glucan from barley. Carbohydr. Res. 1999, 315, 169-179.
18. Ulmius, M., Onning, G., Nilsson, L., Solution behavior of barley beta-glucan as studied with asymmetrical flow field-flow fractionation. Food Hydrocolloids 2012, 26, 175-180.
19. Håkansson, A., Ulmius, M., Nilsson, L., Asymmetrical flow field-flow fractionation enables the characterization of molecular and supramolecular properties of cereal β-glucan dispersions. Carbohydr. Polym. 2012, 87, 518-523.
20. Samuelsen, A. B., Rieder, A., Grimmer, S., Michaelsen, T. E. et al., Immunomodulatory activity of dietary fiber: arabinoxylan and mixed-linked beta-glucan isolated from barley show modest activities in vitro. Int. J. Mol. Sci. 2011, 12, 570-587.
21. Bhatty, R. S., Laboratory and pilot-plant extraction and purification of beta-glucans from hull less barley and oat brans. J. Cereal Sci. 1995, 22, 163-170.
22. Thondre, P. S., Ryan, L., Henry, C. J. K., Barley beta-glucan extracts as rich sources of polyphenols and antioxidants. Food Chem. 2011, 126, 72-77.
23. Czop, J. K., Austen, K. F., Properties of Glycans that activate the human alternative complement pathway and interact with the human monocyte beta-glucan receptor. J. Immunol. 1985, 135, 3388-3393.
24. Estrada, A., Yun, C. H., Van Kessel, A., Li, B. et al., Immunomodulatory activities of oat beta-glucan in vitro and in vivo. Microbiol. Immunol. 1997, 41, 991-998.
25. Roubroeks, J. P., Skjak-Braek, G., Ryan, L., Christensen, B. E., Molecular weight dependency on the production of the TNF stimulated by fractions of rye (1 -> 3), (1 -> 4)-beta-D-glucan. Scand. J. Immunol. 2000, 52, 584-587.
26. Yun, C. H., Estrada, A., Van Kessel, A., Park, B. C. et al., Beta-glucan, extracted from oat, enhances disease resistance against bacterial and parasitic infections. FEMS Immunol. Med. Microbiol. 2003, 35, 67-75.
27. Chan, W. K., Law, H. K. W., Lin, Z. B., Lau, Y. L. et al., Response of human dendritic cells to different immunomodulatory polysaccharides derived from mushroom and barley. Int. Immunol. 2007, 19, 891-899.
28. Goodridge, H. S., Wolf, A. J., Underhill, D. M., Beta-glucan recognition by the innate immune system. Immunol. Rev. 2009, 230, 38-50.
29. Brown, G. D., Dectin-1: a signalling non-TLR pattern-recognition receptor. Nat. Rev. Immunol. 2006, 6, 33-43.
30. Brown, G. D., Gordon, S., Immune recognition. A new receptor for β-glucans. Nature 2001, 413, 36-37.
31. Xia, Y., Vetvicka, V., Yan, J., Hanikyrová, M. et al., The β-glucan-binding lectin site of mouse CR3 (CD11b/CD18) and its function in generationg a primed state of the receptor that mediates cytotoxic activation in response to iC3b-opsonized target cells. J. Immunol. 1999, 162, 2281-2290.
32. Thornton, B. P., Vetvicka, V., Pitman, M., Goldman, R. C., Ross, G. D., Analysis of the sugar specificity and molecular location of the β-glucan-binding lectin site of complement receptor Type 3 (CD11b/CD18). J. Immunol. 1996, 156, 1235-1246.
33. Palma, A. S., Feizi, T., Zhang, Y., Stoll, M. S. et al., Ligands for the β-glucan receptor, Dectin-1, assigned using "designer" microarrays of oligosaccharide probes (neoglycolipids) generated from glucan polysaccharides. J. Biol. Chem. 2006, 281, 5771-5779.
34. Tada, R., Adachi, Y., Ishibashi, K.-I., Tsubaki, K. et al., Binding capacity of a barley β-glucan to the β-glucan recognition molecule Dectin-1. J. Agric. Food Chem. 2008, 56, 1442-1450.
35. Tada, R., Ikeda, F., Aoki, K., Yoshikawa, M. et al., Barley-derived beta-D-glucan induces immunostimulation via a dectin-1-mediated pathway. Immunol. Lett. 2009, 123, 144-148.
36. Direnzo, L., Yefenof, E., Klein, E., The function of human NK cells is enhanced by beta-glucan a ligang of CR3 (CD11B/CD18). Eur. J. Immunol. 1991, 21, 1755-1758.
37. Vetvicka, V., Thornton, B. P., Ross, G. D., Soluble beta-glucan polysaccharide binding to the lectin site of neutrophil or natural killer cell complement receptor type 3 (CD11b/CD18) generates a primed state of the receptor capable of mediating cytotoxicity of iC3b-opsonized target cells. J. Clin. Invest. 1996, 98, 50-61.
38. Lowe, E. P., Wei, D., Rice, P. J., Li, C. F. et al., Human vascular endothelial cells express pattern recognition receptors for fungal glucans which stimulates nuclear factor kappa B activation and interleukin 8 production. Am. Surg. 2002, 68, 508-517.
39. Hahn, P. Y., Evans, S. E., Kottom, T. J., Standing, J. E. et al., Pneumocystis carinii cell wall beta-glucan induces release of macrophage inflammatory protein-2 from alveolar epithelial cells via a lactosylceramide-mediated mechanism. J. Biol. Chem. 2003, 278, 2043-2050.
40. Murphy, E. A., Davis, J. M., Brown, A. S., Carmichael, M. D. et al., Effects of moderate exercise and oat beta-glucan on lung tumor metastases and macrophage antitumor cytotoxicity. J. Appl. Physiol. 2004, 97, 955-959.
41. Cheung, N. K. V., Modak, S., Oral (1 -> 3), (1 -> 4)-beta-D-glucan synergizes with antiganglioside GD2 monoclonal antibody 3F8 in the therapy of neuroblastoma. Clin. Cancer Res. 2002, 8, 1217-1223.
42. Cheung, N. K. V., Modak, S., Vickers, A., Knuckles, B., Orally administered beta-glucans enhance anti-tumor effects of monoclonal antibodies. Cancer Immunol. Immunother. 2002, 51, 557-564.
43. Hong, F., Yan, J., Baran, J. T., Allendorf, D. J. et al., Mechanism by which orally administered beta-1, 3-glucans enhance the tumoricidal activity of antitumor monoclonal antibodies in murine tumor models. J. Immunol. 2004, 173, 797-806.
44. Modak, S., Koehne, G., Vickers, A., O'Reilly, R. J. et al., Rituximab therapy of lymphoma is enhanced by orally administered (1 -> 3), (l -> 4)-D-beta-glucan. Leuk. Res. 2005, 29, 679-683.
45. Xia, Y., Vetvicka, V., Yan, J., Hanikyrova, M. et al., The beta-glucan-binding lectin site of mouse CR3 (CD11b/CD18) and its function in generating a primed state of the receptor that mediates cytotoxic activation in response to iC3b-opsonized target cells. J. Immunol. 1999, 162, 2281-2290.
46. Akramiene, D., Grazeliene, G., Didziapetriene, J., Kevelaitis, E., Treatment of Lewis lung carcinoma by photodynamic therapy and glucan from barley. Med. Lith. 2009, 45, 480-485.
47. Cecic, I., Serrano, K., Gyongyossy-Issa, M., Korbelik, M., Characteristics of complement activation in mice bearing Lewis lung carcinomas treated by photodynamic therapy. Cancer Lett. 2005, 225, 215-223.
48. Yun, C. H., Estrada, A., Van Kessel, A., Gajadhar, A. et al., Immunomodulatory effects of oat beta-glucan administered intragastrically or parenterally on mice infected with Eimeria vermiformis. Microbiol. Immunol. 1998, 42, 457-465.
49. Yun, C. H., Estrada, A., VanKessel, A., Gajadhar, A. A. et al., Beta-(1->3, 1->4) oat glucan enhances resistance to Eimeria vermiformis infection in immunosuppressed mice. Int. J. Parasit. 1997, 27, 329-337.
50. Davis, J. M., Murphy, E. A., Brown, A. S., Carmichael, M. D. et al., Effects of moderate exercise and oat beta-glucan on innate immune function and susceptibility to respiratory infection. Am. J. Physiol.-Regul. Integr. Comp. Physiol. 2004, 286, R366-R372.
51. Davis, J. M., Murphy, E. A., Brown, A. S., Carmichael, M. D. et al., Effects of oat beta-glucan on innate immunity and infection after exercise stress. Med. Sci. Sports Exerc. 2004, 36, 1321-1327.
52. Murphy, E. A., Davis, J. M., Brown, A. S., Carmichael, M. D. et al., Benefits of oat beta-glucan on respiratory infection following exercise stress: role of lung macrophages. Am. J. Physiol.-Regul. Integr. Comp. Physiol. 2008, 294, R1593-R1599.
53. Murphy, E. A., Davis, J. M., Carmichael, M. D., Mayer, E. P. et al., Benefits of oat beta-glucan and sucrose feedings on infection and macrophage antiviral resistance following exercise stress. Am. J. Physiol.-Regul. Integr. Comp. Physiol. 2009, 297, R1188-R1194.
54. Murphy, E. A., Davis, J. M., Brown, A. S., Carmichael, M. D. et al., Oat beta-glucan effects on neutrophil respiratory burst activity following exercise. Med. Sci. Sports Exerc. 2007, 39, 639-644.
55. Estrada, A., van Kessel, A., Laarveld, B., Effect of administration of oat beta-glucan on immune parameters of healthy and immunosuppressed beef steers. Can. J. Vet. Res.-Rev. Can. Rech. Vet. 1999, 63, 261-268.
56. Nieman, D. C., Henson, D. A., McMahon, M., Wrieden, J. L. et al., Beta-glucan, immune function, and upper respiratory tract infections in athletes. Med. Sci. Sports Exerc. 2008, 40, 1463-1471.
57. Theuwissen, E., Plat, J., Mensink, R. P., Consumption of oat beta-glucan with or without plant stanols did not influence inflammatory markers in hypercholesterolemic subjects. Mol. Nutr. Food Res. 2009, 53, 370-376.
58. Queenan, K. M., Stewart, M. L., Smith, K. N., Thomas, W. et al., Concentrated oat beta-glucan, a fermentable fibre, lowers serum cholesterol in hypercholesterolemic adults in a randomized controlled trial. Nutr. J. 2007, 6, 6.
59. Johansen, H. N., Knudsen, K. E. B., Wood, P. J., Fulcher, R. G., Physico-chemical properties and the degradation of oat bran polysaccharides in the gut of pigs. J. Sci. Food Agric. 1997, 73, 81-92.
60. Johansen, H. N., Wood, P. J., Knudsen, K. E. B., Molecular-weight changes in the (1-]3)(1-]4)-beta-D-glucan of oats incurred by the digestive processes in the upper gastrointestinal-tract of pigs. J. Agric. Food Chem. 1993, 41, 2347-2352.
61. Ramakers, J. D., Volman, J. J., Biorklund, M., Onning, G. et al., Fecal water from ileostomic patients consuming oat beta-glucan enhances immune responses in enterocytes. Mol. Nutr. Food Res. 2007, 51, 211-220.
62. Sundberg, B., Wood, P., Lia, A., Andersson, H. et al., Mixed-linked beta-glucan from breads of different cereals is partly degraded in the human ileostomy model. Am. J. Clin. Nutr. 1996, 64, 878-885.
63. Hughes, S. A., Shewry, P. R., Gibson, G. R., McCleary, B. V. et al., In vitro fermentation of oat and barley derived beta-glucans by human faecal microbiota. FEMS Microbiol. Ecol. 2008, 64, 482-493.
64. Crittenden, R., Karppinen, S., Ojanen, S., Tenkanen, M. et al., in vitro fermentation of cereal dietary fibre carbohydrates by probiotic and intestinal bacteria. J. Sci. Food Agric. 2002, 82, 781-789.
65. Mitsou, E. K., Panopoulou, N., Turunen, K., Spiliotis, V. et al., Prebiotic potential of barley derived beta-glucan at low intake levels: a randomised, double-blinded, placebo-controlled clinical study. Food Res. Int. 2010, 43, 1086-1092.
66. Rice, P. J., Adams, E. L., Ozment-Skelton, T., Gonzalez, A. J. et al., Oral delivery and gastrointestinal absorption of soluble glucans stimulate increased resistance to infectious challenge. J. Pharmacol. Exp. Ther. 2005, 314, 1079-1086.
67. Sandvik, A., Wang, Y. Y., Morton, H. C., Aasen, A. O. et al., Oral and systemic administration of beta-glucan protects against lipopolysaccharide-induced shock and organ injury in rats. Clin. Exp. Immunol. 2007, 148, 168-177.
68. Hashimoto, K., Suzuki, I., Yadomae, T., Oral administration of SSG, a beta-glucan obtained from sclerotinia-sclerotiorum, affects the function of Peyers patch cells. Int. J. Immunopharmacol. 1991, 13, 437-442.
69. Suzuki, I., Tanaka, H., Kinoshita, A., Oikawa, S. et al., Effect of orally-administered beta-glucan on macrophage function in mice. Int. J. Immunopharmacol. 1990, 12, 675-684.
70. Gebert, A., Rothkotter, H. J., Pabst, R., M cells in Peyer's patches of the intestine. Int. Rev. Cytol. 1996, 167, 91-159.
71. Neutra, M. R., Kraehenbuhl, J. P., in: Mestecky, J., Lamm, M. E., McGhee, J. R., Bienenstock, J. et al. (Eds.), Mucosal Immunology, Elsevier, New York 2005, pp. 111-130.
72. Sakurai, T., Hashimoto, K., Suzuki, I., Ohno, N. et al., Enhancement of murine alveolar macrophage functions by orally-administered beta-glucan. Int. J. Immunopharmacol. 1992, 14, 821-830.
73. Kato, T., Owen, R. L., in: Ogra, P. L., Strober, W., Mestecky, J., Lamm, M. E. et al. (Eds.), Handbook of Mucosal Immunology, Academic Press, San Diego, CA 1994, pp. 11-26.
74. Yamada, H., Kiyohara, H., in: Boons, G.-J., Lee, Y. C., Suzuki, A., Taniguchi, N. et al. (Eds.), Cell Glycobiology and Development Health and Disease in Glycomedicine, Elsevier, Oxford 2007, pp. 664-693.
75. Mayer, L., Blumberg, R. S., in: Mestecky, J., Lamm, M. E., McGhee, J. R., Bienenstock, J. et al. (Eds.), Mucosal Immunology, Elsevier, New York 2005, pp. 435-450.
76. Florence, A. T., The oral absorption of micro- and nanoparticulates: neither exceptional nor unusual. Pharm. Res. 1997, 14, 259-266.
77. Volman, J. J., Mensink, R. P., Buurman, W. A., Onning, G. et al., The absence of functional dectin-1 on enterocytes may serve to prevent intestinal damage. Eur. J. Gastroenterol. Hepatol. 2010, 22, 88-94.
78. Rieder, A., Grimmer, S., Kolset, S. O., Michaelsen, T. E. et al., Cereal beta-glucan preparations of different weight average molecular weights induce variable cytokine secretion in human intestinal epithelial cell lines. Food Chem. 2011, 128, 1037-1043.
79. Haller, D., Bode, C., Hammes, W. P., Pfeifer, A. M. A. et al., Non-pathogenic bacteria elicit a differential cytokine response by intestinal epithelial cell/leucocyte co-cultures. Gut 2000, 47, 79-87.
80. Volman, J. J., Mensink, R. P., Ramakers, J. D., de Winther, M. P. et al., Dietary (1 -> 3), (1 -> 4)-beta-D-glucans from oat activate nuclear factor-kappa B in intestinal leukocytes and enterocytes from mice. Nutr. Res. 2010, 30, 40-48.
81. Murphy, K., Travers, P., Walter, P., Janeway's Immunobiology, Garland Sciences, Taylor & Francis Group, LLC, New York and London 2008.
82. Tsukada, C., Yokoyama, H., Miyaji, C., Ishimoto, Y. et al., Immunopotentiation of intraepithelial lymphocytes in the intestine by oral administrations of beta-glucan. Cell Immunol. 2003, 221, 1-5.
83. Leung, M. Y. K., Liu, C., Koon, J. C. M., Fung, K. P., Polysaccharide biological response modifiers. Immunol. Lett. 2006, 105, 101-114.
84. Schepetkin, I. A., Quinn, M. T., Botanical polysaccharides: macrophage immunomodulation and therapeutic potential. Int. Immunopharmacol. 2006, 6, 317-333.
85. AbuMweis, S. S., Jew, S., Ames, N. P., Beta-glucan from barley and its lipid-lowering capacity: a meta-analysis of randomized, controlled trials. Eur. J. Clin. Nutr. 2010, 64, 1472-1480.
86. Behall, K. M., Scholfield, D. J., Hallfrisch, J. G., Barley beta-glucan reduces plasma glucose and insulin responses compared with resistant starch in men. Nutr. Res. 2006, 26, 644-650.
87. Hallfrisch, J., Scholfield, D. J., Behall, K. M., Physiological responses of men and women to barley and oat extracts (Nu-trimX). II. Comparison of glucose and insulin responses. Cereal Chem. 2003, 80, 80-83.
88. Wolever, T. M. S., Tosh, S. M., Gibbs, A. L., Brand-Miller, J. et al., Physicochemical properties of oat beta-glucan influence its ability to reduce serum LDL cholesterol in humans: a randomized clinical trial. Am. J. Clin. Nutr. 2010, 92, 723-732.
89. Wood, P. J., Braaten, J. T., Scott, F. W., Riedel, K. D. et al., Effect of dose and modification of viscous properties of oat gum on plamsa-glucose and insulin following an oral glucose-load. Br. J. Nutr. 1994, 72, 731-743.
90. Tiwari, U., Cummins, E., Meta-analysis of the effect of beta-glucan intake on blood cholesterol and glucose levels. Nutrition 2011, 27, 1008-1016.
91. Gemen, R., de Vries, J. F., Slavin, J. L., Relationship between molecular structure of cereal dietary fiber and health effects: focus on glucose/insulin response and gut health. Nutr. Rev. 2011, 69, 22-33.
92. Gunness, P., Gidley, M. J., Mechanisms underlying the cholesterol-lowering properties of soluble dietary fibre polysaccharides. Food Funct. 2010, 1, 149-155.